A Cost Effectiveness Analysis Of A General Vaccination Programme With The New 10-Valent Pneumococcal Non-Typeable Haemophilus Influenzae Protein-D Conjugate Vaccine (Phid-Cv) In Sweden
(2009) In Value in Health 12(3). p.165-165
Please use this url to cite or link to this publication:
https://lup.lub.lu.se/record/1426530
- author
- Bergman, Annika ; Borg, Sixten LU ; Sobocki, P. and Persson, U.
- publishing date
- 2009
- type
- Contribution to journal
- publication status
- published
- subject
- in
- Value in Health
- volume
- 12
- issue
- 3
- pages
- 165 - 165
- publisher
- Wiley-Blackwell
- external identifiers
-
- wos:000265236700818
- ISSN
- 1098-3015
- language
- English
- LU publication?
- no
- id
- 9bc80028-6108-48ef-8337-2d2fd0259c92 (old id 1426530)
- alternative location
- http://www.sciencedirect.com/science/article/pii/S1098301510738869
- date added to LUP
- 2016-04-01 12:10:08
- date last changed
- 2018-11-21 20:04:33
@misc{9bc80028-6108-48ef-8337-2d2fd0259c92, author = {{Bergman, Annika and Borg, Sixten and Sobocki, P. and Persson, U.}}, issn = {{1098-3015}}, language = {{eng}}, note = {{Conference Abstract}}, number = {{3}}, pages = {{165--165}}, publisher = {{Wiley-Blackwell}}, series = {{Value in Health}}, title = {{A Cost Effectiveness Analysis Of A General Vaccination Programme With The New 10-Valent Pneumococcal Non-Typeable Haemophilus Influenzae Protein-D Conjugate Vaccine (Phid-Cv) In Sweden}}, url = {{http://www.sciencedirect.com/science/article/pii/S1098301510738869}}, volume = {{12}}, year = {{2009}}, }